Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Protect Pharmaceutical Corporation    PRTT

PROTECT PHARMACEUTICAL CORPORATION

(PRTT)
SummaryQuotesChartsNewsCompany 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Protect Pharmaceutical Corporation Acquires Tobit Clicks

10/20/2018 | 01:14pm EST

LAS VEGAS, Oct. 20, 2018 (GLOBE NEWSWIRE) -- Protect Pharmaceuticals Corporation (OTC: PRTT), a Nevada Corporation, acquired Las Vegas based Tobit LLC’s business model Tobit Clicks (https://tobitclicks.com/) and 80 % of it’s ERC -20 Tokens (8,000,000 Tobits). PRTT also acquired it’s related digital assets and intellectual property.

Tobit Clicks is a first of its kind crypto powered traffic exchange and sales platform. Tobit Clicks provides brand awareness and generate real sales with its online gamified crypto token incentivized sales system. The platform will help accelerate growth in companies that are part of the Tobit Consortium and create awareness of those companies by members of the global cryptocurrency community.

Yvette Sanchez, PRTT’s President shared, “This acquisition will allow new members of the Tobit Consortium to exponentially grow their product adoption rates and revenue. This adds another foundational piece needed to power the next wave of innovation in blockchain applications.”

Tobit Clicks is a platform designed to reward all who participate. My desire was to build a platform where anyone could have an opportunity to earn crypto-tokens for completing even the simplest of tasks such as viewing ads or helping another member of the community. We believe a person’s time is one of their most precious assets, through the power of the blockchain we now have the ability to transfer real value in exchange for that time.” stated Damien Ramos CEO and Founder of the Tobit LLC and Tobit Consortium.

Forward-Looking Statements: This press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as “may”, “will”, “to”, “plan”, “expect”, “believe”, “anticipate”, “intend”, “could”, “would”, “estimate,” or “continue”, or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements. Forward-looking statements involve known and unknown risk, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date hereof. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company's filings with the SEC including the Current Reports on Form 8-K and the Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

For more information contact:
Protect Pharmaceutical Corporation
954-866-3726

© GlobeNewswire 2018
All news about PROTECT PHARMACEUTICAL CORPORATION
2020PROTECT PHARMACEUTICAL : Agrees to be Acquired by Novgorod Group
AQ
2020Protect Pharmaceutical's Agrees to be Acquired by Novgorod Group
GL
2020Protect Pharmaceutical's Agropharm A Fertilizer Shown To Increase Crop Yields..
GL
2020Protect Pharmaceutical Announces Construction of Two New Agropharm Production..
GL
2020PROTECT PHARMACEUTICAL : Successfully Deploys Agropharm A, Obtains DTC Eligibili..
AQ
2020PROTECT PHARMACEUTICAL COMMENCES PRO : Cannabis-Based “Green Wine”
AQ
2020Protect Pharmaceutical Acquires 60 Hectares in Selva Girona to Showcase Agrop..
GL
2020Protect Pharmaceutical Acquires the Hotel Albons in Spain and Adds New Direct..
GL
2020PROTECT PHARMACEUTICAL : Acquires Mastnak Winery, Solidifying Award-Winning Wine..
AQ
2018AES and OnliFunds Launches OnliChain focused $250 million Fund.
GL
More news
Chart PROTECT PHARMACEUTICAL CORPORATION
Duration : Period :
Protect Pharmaceutical Corporation Technical Analysis Chart | PRTT | US74364W2035 | MarketScreener
Managers and Directors
NameTitle
Alan Crooks Chief Executive Officer & Director
Sector and Competitors
1st jan.Capitalization (M$)
PROTECT PHARMACEUTICAL CORPORATION8.33%26
JOHNSON & JOHNSON1.86%421 997
ROCHE HOLDING AG2.48%305 385
NOVARTIS AG1.97%218 041
MERCK & CO., INC.1.93%210 954
PFIZER INC.-0.30%203 993